Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), leads to the dysregulation of the immune system …

Coronavirus disease 2019 (COVID-19) has been associated with dysregulation of the
immune system featuring inappropriate immune responses, exacerbation of inflammatory …

Background: In the setting of the current pandemic, concerns have arisen regarding the
multisystemic involvement of sarcoidosis and the possible exacerbations in response to the …

Data on the clinical presentation and outcomes of sarcoidosis patients with coronavirus
disease 19 (COVID-19) are scarce. In this case series, we identified 5 out of 238 sarcoidosis …

Methods: Articles discussing biopsy-proven sarcoidosis after confirmed COVID-19 infection,
published 1956 until April 2023, were included. All article types were deemed eligible …

The COVID‐19 pandemic has been a worldwide medical challenge. Despite rapid
advancements, many questions regarding SARS‐CoV‐2 interaction with other pathologies …

COVID-19 infection in patients with sarcoidosis: susceptibil... : Current Opinion in Pulmonary
Medicine COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes …

Recent case reports and studies on treating COVID-19 in patients with chronic sarcoidosis
describe different treatment modalities ranging from glucocorticoids to biologic medications …

Objective: To investigate the prevalence, clinical features and outcomes of coronavirus
disease 2019 (COVID-19) among sarcoidosis patients. Methods: We retrospectively …

Background: Inspired by intense challenges encountered by patients and clinicians, we
examined the experiences of living with sarcoidosis in three of the hardest impacted English …